Human Medicines
This area of the website provides information relating to the regulation of human medicines, including access to product information, pharmacovigilance and the directory of relevant agencies.
HUMAN MEDICINES | RECENTLY PUBLISHED
IMPLEMENTATION OF THE VARIATIONS FRAMEWORK
Marketing authorisation holders…
modified 07/11/2025
Added in November 2025
07 November
UPDATE - Contact Points
04…
modified 07/11/2025
Contact Points
modified 07/11/2025
Riamet (artemether / lumefantrine)UK/W/0096/pdWS/001End of procedure:…
modified 06/11/2025
Xalatan / Latanoprost Viatris (latanoprost)End of procedure: 18/09/2024Date of…
modified 23/10/2025
National information on MAH transfers (May 2025)
modified 23/10/2025
Post-Brexit (October 2025)
added 23/10/2025
Templates - DCP (AR/Comments) · D70 Preliminary AR and D120 Draft AR
modified 23/10/2025
Panzyga and associated names (human normal immunoglobin…
modified 23/10/2025
Hiberix (haemophilus influenzae type b polysaccharide (PRP) conjugated to…
modified 23/10/2025